Jakarta – Head of the National Agency of Drug and Food Control (BPOM), Penny Lukito, has said that the company is aiming to begin production of the Red and White vaccine in the 2nd half of 2022.
” The Red and White vaccine (developed) from the partnership in between Airlangga University and PT.
The production of the vaccine established by Bio Farma and Baylor College Medicine is also targeted to start in the second half of 2022, she added.
She stated the company will soon issue emergency-use permission (EUA) for booster vaccines.
” Currently, vaccines that are in the registration process to be utilized as boosters are Pfizer, AstraZeneca, Zlifivax, and CoronaVac or Biofarma’s COVID-19 vaccine, while the Sinopharm vaccine is still in the pre-registration procedure,” she included.
BPOM has actually so far permitted Favipiravir, Remdesivir, and Regdanvimab for emergency situation use.
Related news: Hope Red and White vaccine production commences in 2022: minister
” After the issuance of the emergency-use authorization, we perform post-market security to make sure the drugs are being distributed appropriately, in addition to (conduct) pharmacovigilance of unfavorable events following immunization or AEFIs,” she described.
The Indonesian government released a nationwide vaccination program on January 13, 2021, in a bid to improve resistance against COVID-19
According to information offered by the Health Ministry, since December 29, 2021, nearly 159,269,210 people have received their first COVID-19 jab, while 112,595,665 have actually been totally vaccinated versus the infection.
The federal government is planning to commence administering the third dose or booster vaccines in January2022
Related news: East Java Governor supports Red and White Vaccine medical trial
